Ads
related to: Acute Myeloid Leukemia- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Dosing & Monitoring
Search results
Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
Alaska Superstation· 3 days agoSeniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WJTV Jackson· 2 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
Anti-diabetic treatment associated with reduced risk of developing blood cancer
Medical Xpress· 2 hours agoMetformin is a therapy used to treat high blood sugar in people with type 2 diabetes that increases...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoMoleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress PR Newswire HOUSTON, May 16, 2024 HOUSTON, May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or
After 25 years selling Harleys, Gail Worth will soon close KC business. She has plans
Kansas City Star via Yahoo Finance· 3 days ago“He was my best friend in my whole life,” Worth said of Adams, who died in April after battling ...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 2 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 3 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid ...
Actinium Announces Multiple Abstracts Highlighting its Antibody Radiation Conjugates Iomab-B and...
WJTV Jackson· 4 days agoIomab-B and Actimab-A are the only targeted radiotherapies in development for patients with relapsed/refractory acute myeloid leukemia
Former patients reunite as professionals at UPMC Children's Hospital of Pittsburgh
Pittsburgh Tribune-Review· 5 hours agoDr. Matt Kocher was setting up an operating room during his anesthesia fellowship at UPMC Children’s...
Local Leukemia & Lymphoma Society holds annual fundraiser for blood cancer research
Local 12 Cincinnati· 21 hours agoThe local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for...
Ads
related to: Acute Myeloid Leukemia